megfk

Author Archives

Options, understandings and tactics

Alan – We open here a forum for discussing options. It might be helpful to open the discussion with a copy of the paragraphs that I wrote 4/24 about options. I don’t know how to cut-and-paste that material. Before I opened this discussion forum, I noticed a question about choosing a stock that might perform […]

Recent Author Comments

On Microblog: The Zed Files
Dr. KSS...You asked what methylfolate is thought to do in refractory depression. I recently did some research on the role of methylation and sulfation as they come together with great effectiveness after the addition of lithium. The lithium (either lithi[...]
On Microblog: Oxidation for Health...Physical and Fiscal
les walter----My college roommate had two fistulas open a short time after starting chemotherapy. One fistula was from bowel to bladder, therefore poop in the urine. The second was from bowel, exit the vagina. She experienced a lot of pain from the abra[...]
On May Idea of the Month: Online Advertising IPO Washout
Stefan...If it is NOT different, then some internet stocks will go bankrupt or be bought out, and others will reward investors for the next 12 years. There will surely be online ad companies into the future. Maybe CRTO will be a survivor. Given that i[...]
On Microblog: Guaranteed Weight Loss without Surgery, Drugs or Dieting! (Really!)
Often I have observed that a person who successfully lost weight will quickly regain it, plus adding more pounds on top of that. This seems to be the case when someone lost weight during an illness, too. One woman was staying on a diet of 400 calorie[...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
Alan - Many thanks for posting material on the option thread. I hope that you saw the words of appreciation for you from people posting there. On that microblog, our first goal is to identify things that make a good underlying stock for an option pla[...]
On Microblog: Options, understandings and tactics
Blind DayTrader - Your topic was too advanced for me, and was obviously a pleasure for both Lawrence McKenna and Frank Archambeau. Those with your capabilities will enjoy joining your discussion threads. I will read things that you all are talking abou[...]
On Microblog: Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
Dr. KSS... If I failed to appropriately respond to things you said to me, you maybe can chalk that up to my lack of comprehension, and certainly to my perspective regarding "truth." I do not think that anyone has fully grasped "truth" about anything. Un[...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
Alan has established our website for discussing options - www.stockgumshoe.com/2014/04/microblog-options-understandings-and-tactics/#comment-455046 This options site is for those who have never tried an option play. It is also a discussion forum for [...]
On Microblog: Options, understandings and tactics
KennyG says, Class is in session. We are a class with a huge difference in experience and in knowledge of options. The Blind DayTrader and lawrence mckenna talk a language many will not understand at all. Others wonder how to start an option play, [...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
In 1969, there was a big push to eradicate the mosquito by infiltrating mosquito populations with a super-male that was sterile. Some scientists identified a sterile male, but could not duplicate him. I fully expected another, similar plan to have gotten[...]
On Microblog: Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
Dr. KSS -- Thank-you for conveying so thoroughly your approach to treating hepatic encephalopathy. But I do still expect to see a mermaid, and the Loch Ness monster, too. As I understand your view of ammonia in regard to mental confusion...although p[...]
On Microblog: Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
Dr. KSS -- Please know that it was not my intention to "dispute" everything you say about a topic. I simply asked you a question. I will ask it again, providing more detail about the patient's situation. I posed a situation in which the patient has [...]
On Microblog: Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
tanglewood - Dr. Johanna Budwig (in Germany) treated cancer patients with Flaxseed oil, based on the work of oil chemists that revealed deficiencies of linoleic acid in people with cancer). Even though all the patients were viewed as beyond help, the Fl[...]
On Microblog: Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
Thank-you, Ray, for telling about this study.[...]
On Microblog: Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
It would be fun to listen in on this husband and wife as they chat, wouldn't it?![...]
On Microblog: Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
Dr. KSS - Nonetheless, ammonia levels are measured when a patient is in liver failure (decompensation). And patients are given a product such as Lactulose to help expel ammonia and bring down the levels. As ammonia levels rise, speech and movements of [...]
On Microblog: Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
Doc GumShoe - I did not keep my copy of the study on Vitamin K. And I do not know whether it was published. In 1999, my doctor (who held to the party-line of anti-supplements) went with other doctors from his clinic to a presentation at Bethesda Hospit[...]
On Microblog: Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
Kris, I'm glad that you caught my mistake. I checked my bottle - - and you are correct. It is Vitamin K2 that I take. And now I know that K3 is one to avoid.[...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
Alan - I suppose that it fell with the sector. I track a few other biotechs thatfell 50% or more, also. But I'm recalling that biotech, over-all, had a 28% pull-back. Today, someone (in a Yahoo video) said that the IBB is on the verge of breaking below[...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
Kris - So they expect RGDO to more than double. That's good news.[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch